Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 75-81

  Anzai, Yoshimi ^a   Prince, Martin R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Head and neck cancer; Iron oxide; Lymph node metastasis; MR contrast; MR imaging

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STRUCTURE; HEAD AND NECK CANCER; LYMPH NODE METASTASIS; LYMPHOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW;

CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FERRIC COMPOUNDS; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; LYMPHATIC METASTASIS; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0031404188     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070111     Document Type: Review

References (41)

1. Batsakis JG. Squamous cell carcinoma of the oral cavity and the oropharynx. In: Batsakis JG ed. Tumors of the head and neck: clinical and pathological considerations, 2nd ed. Baltimore: Williams & Wilkins, 1979; 240-250.
2. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29:1446-1449.
3. Bocca E, Calearo C, de Vincentiis I, Marullo T, Motta G, Ottaviani A. Occult metastases in cancer of the larynx and their relationship to clinical and histological aspects of the primary tumor: a four-year multicentric research. Laryngoscope 1984; 94:1086-1090.
4. Friedman M, Roberts N, Kirshenbaum G, Colombo J. Nodal size of metastatic squamous cell carcinoma of the neck. Laryngoscope 1993; 103:854-856.
5. Johnson JT. A surgeon looks at cervical lymph nodes. Radiology 1990; 177:607-610.
6. Mancuso AA, Harnsberger HR, Muraki AS, Stevens MH. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal and applications in staging head and neck cancer. Part I: Normal anatomy. Radiology 1983; 148:709-714.
7. Som PM. Lymph nodes of the neck. Radiology 1987; 165:593-600.
8. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992; 158:961-969.
9. Mancuso AA, Maceri D, Rice D, Hanafee WN. CT of cervical lymph node cancer. AJR Am J Roentgenol 1981; 136:381-385.
10. Mancuso AA, Harnsberger HR, Muraki AS, Stevens MH. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging of head and neck cancer. Part II: Pathology. Radiology 1983; 148:715-723.
11. van den Brekel MWM, Stel HV, Castelijins JA, et al. Cervical lymph node metastases: assessing of radiological criteria. Radiology 1990; 177:379-384.
12. van den Brekel MWM, Castelijins JA, Stel HV, et al. Detection and characterization of metastatic cervical adenopathy by MR imaging: comparison of different MR techniques. J Comput Assist Tomogr 1990; 14:581-589.
13. Snyderman NL, Johnson JT, Schramm VL, Meyers EN, Bedetti CD, Thearle P. Extracapsular spread of carcinoma in cervical lymph nodes. Cancer 1985; 56:1597-1599.
14. Jinkins JR. Computed tomography of the craniocervical lymphatic system: anatomical and functional considerations. Neuroradiology 1987; 29:317-326.
15. Dooms GC, Hricak H, Crooks LE, et al. Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 1984; 153:719-728.
16. Dooms GC, Hricak H, Moseley MR, Bottles K, Fisher MR, Higgins CB. Characterization of lymphadenopathy by magnetic relaxation times: preliminary results. Radiology 1985; 155:691-697.
17. Tien RD, Robbins KT. Correlation of clinical, pathologic, and MR fat suppression results for head and neck cancer. Head Neck 1992; 14:278-284.
18. Barakos JA, Dillon WP, Chew WM. Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging. Radiology 1991; 179:191-198.
19. Yousem D, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992; 182:753-759.
20. Anzai Y, McLachlan S, Saxton R, Moris M, Lufkin RB. Dextrancoated superparamagnetic iron oxide: an MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol 1994; 15:87-94.
21. McLachlan S, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994; 4:301-307.
22. Anzai Y, Blackwell K, Hirschowitz S, et al. Initial clinical experience with Dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994; 192:709-715.
23. Saini S, Stark DD, Hahn PF, Wittneberg J, Brady TJ, Ferrucci JT. Ferrite particles: a superparamagnetic MR contrast agent for the reticularendothelial system. Radiology 1987; 162:211-216.
24. Stark DD, Weissleder RR, Elizondo CT, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168:297-301.
25. Weissleder R, Hahn PF, Stark DD, et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 1988; 169:399-403.
26. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152:167-173.
27. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
28. Weissleder R, Heautot JF, Schaffer BK, et al. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology 1994; 191:225-230.
29. Weissleder R, Elizondo CT, Wittenberg J, Lee AS, Josephson L, Brady T. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
30. Ross PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196:481-488.
31. Weissleder R, Elizondo CT, Josephson L, et al. Experimental lymph nodes metastases: enhanced detection with MR lymphography. Radiology 1989; 171:835-839.
32. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, Ferumoxtran, Ferumoxsil. Magn Reson Imaging 1995; 13:661-674.
33. Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, Ferumoxtran, Ferumoxsil. Magn Reson Imaging 1995; 13:675-691.
34. Hudgins P, Anzai Y, Morris M. Dextran-coated superparamagnetic iron oxide MR contrast agent (Combidex™) for imaging cervical lymph nodes: optimal dose, time of imaging, and pulse sequence (abstract). Presented at the 1996, Los Angeles, American Society of Neuroradiology, Seattle, 1996: 269.
35. Vasallo P, Matel C, Heston WDW, McLachlan SJ, Koutcher JA, Castellino RA. AMI 227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994; 193:501-506.
36. Tanoura T, Bernas M, Darkazani A, et al. MR lymphography with iron oxide compound AMI 227: studies in ferrets with filariasis. AJR Am J Roentgenol 1992; 159:875-881.
37. Taupitz M, Wagner S, Hamm B, Binder A, Pfefferer D. Interstitial MR lymphography with Iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits. AJR Am J Roentgenol 1993; 161:193-200.
38. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994; 162:209-213.
39. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn P. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR Am J Roentgenol 1996; 166:73-77.
40. Anzai Y, Prince MR, Chenevert TL, Maki JH, McLachlan SJ. MR angiography with a dextran-coated ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997; 7:213-218.
41. Lee AS, Weissleder R, Brady TJ, Wittenberg J. Lymph nodes: microstructural anatomy at MR imaging. Radiology 1991; 178: 519-522.